Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma : A multicentre, single-arm phase I/II clinical trial

dc.contributor.authorPili, R.
dc.contributor.authorLiu, G.
dc.contributor.authorChintala, S.
dc.contributor.authorVerheul, H.
dc.contributor.authorRehman, S.
dc.contributor.authorAttwood, K.
dc.contributor.authorLodge, M.
dc.contributor.authorWahl, R.
dc.contributor.authorMartin, J.
dc.contributor.authorGodoy Sánchez, Alejandro Samuel
dc.contributor.authorMiles, K.
dc.contributor.authorPaesante, S.
dc.contributor.authorAdelaiye, R.
dc.contributor.authorKing, S.
dc.contributor.authorZwiebel, J.
dc.contributor.authorCarducci, M.
dc.date.accessioned2021-05-22T01:08:50Z
dc.date.available2021-05-22T01:08:50Z
dc.date.issued2017
dc.format.extent10 páginas
dc.fuente.origenConveris
dc.identifier.doi10.1038/bjc.2017.33
dc.identifier.eissn1532-1827
dc.identifier.issn0007-0920
dc.identifier.urihttps://doi.org/10.1038/bjc.2017.33
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/58573
dc.issue.numeroNo. 7
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final883
dc.pagina.inicio874
dc.revistaBritish Journal of Canceres_ES
dc.rightsacceso abierto
dc.titleCombination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma : A multicentre, single-arm phase I/II clinical triales_ES
dc.typeartículo
dc.volumenVol. 116
sipa.codpersvinculados1011486
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal.pdf
Size:
1.4 MB
Format:
Adobe Portable Document Format
Description: